Acevedo H F, Krichevsky A, Campbell-Acevedo E A, Galyon J C, Buffo M J, Hartsock R J
Department of Pathology and Laboratory Medicine, Allegheny General Hospital, Pittsburgh, PA 15212.
Cancer. 1992 Apr 1;69(7):1829-42. doi: 10.1002/1097-0142(19920401)69:7<1829::aid-cncr2820690727>3.0.co;2-0.
The expression of human chorionic gonadotropin (hCG), its subunits, and fragments on the cell membrane of cultured human cancer cells was investigated using a flow cytometric method. This method uses living cells; a double-antibody reaction; a flow cytometer with an argon laser, standard settings, and filters for fluorescein isothiocyanate; commercially available software; the American Type Culture Collection (ATCC) CCL 2 HeLa cell line as cell control and overall quality control; polyclonal rabbit antisera raised against the hCG dimer, its alpha subunit (hCG alpha), and its beta subunit (hCG beta); and a panel of monoclonal antibodies (MoAb) recognizing different epitopes on the intact hCG molecule, its subunits, and fragments. The purified immunoglobulin G fractions from the polyclonal antisera were used to estimate the total expression of the membrane-associated glycoproteins; the MoAb were used to detect the expression of epitopes of the hCG dimer, its subunits, and fragments. The results of the analyses done on cells from 74 established cancer cell lines of different types and origins (including 52 carcinomas, 10 sarcomas, 4 leukemias, 6 lymphomas, and 2 retinoblastomas) showed variable degrees of reactivity in a great percentage of cells in all cell lines studied with MoAb directed against different conformational epitopes of intact hCG (hCG-holo), hCG beta, hCG beta-free, the carboxy terminal peptide (CTP) of hCG beta, and an epitope of hCG alpha. The expression of the membrane-associated epitopes of hCG and its subunits was found to be a phenotypic marker characteristic of all evaluated cultured human cancer cell lines, irrespective of their type or origin. There were, however, quantitative and qualitative differences in the expression of the different epitopes. Thus, hCG beta, free and as part of hCG-holo, recognized by the MoAb against hCG beta-CTP, was expressed by a high percentage of cells of most cell lines. There was great variability in the expression of hCG-holo, recognized by MoAb B109. For this reason some groups of cancers expressed larger amounts of incompetent hCG alpha and/or hCG beta than others. Cell lines derived from adenocarcinomas of the lung were the only exception to this general finding; the expression of small amounts of hCG-holo was caused by a low degree of hCG alpha synthesis.
采用流式细胞术研究了人绒毛膜促性腺激素(hCG)及其亚基和片段在培养的人癌细胞细胞膜上的表达。该方法使用活细胞;双抗体反应;配备氩离子激光器、标准设置以及异硫氰酸荧光素滤光片的流式细胞仪;市售软件;美国典型培养物保藏中心(ATCC)的CCL 2 HeLa细胞系作为细胞对照和全面质量控制;针对hCG二聚体、其α亚基(hCGα)和β亚基(hCGβ)制备的兔多克隆抗血清;以及一组识别完整hCG分子、其亚基和片段上不同表位的单克隆抗体(MoAb)。来自多克隆抗血清的纯化免疫球蛋白G组分用于估计膜相关糖蛋白的总表达;MoAb用于检测hCG二聚体、其亚基和片段表位的表达。对来自74种不同类型和来源的已建立癌细胞系(包括52种癌、10种肉瘤、4种白血病、6种淋巴瘤和2种视网膜母细胞瘤)的细胞进行分析的结果显示,在所研究的所有细胞系中,很大比例的细胞对针对完整hCG(hCG - 全分子)、hCGβ、无hCGβ、hCGβ羧基末端肽(CTP)以及hCGα一个表位的不同构象表位的MoAb表现出不同程度的反应性。发现hCG及其亚基的膜相关表位的表达是所有评估的培养人癌细胞系的一种表型标记特征,无论其类型或来源如何。然而,不同表位的表达在定量和定性上存在差异。因此,针对hCGβ - CTP的MoAb识别的游离hCGβ以及作为hCG - 全分子一部分的hCGβ,在大多数细胞系的很大比例细胞中表达。被MoAb B109识别的hCG - 全分子的表达存在很大变异性。因此,某些癌症组比其他组表达更多无功能的hCGα和/或hCGβ。来自肺腺癌的细胞系是这一普遍发现的唯一例外;少量hCG - 全分子的表达是由于hCGα合成程度低所致。